Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2011
06/09/2011US20110136844 Methods for inhibiting dyrk1a to treat central nervous system diseases and disorders
06/09/2011US20110136843 Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
06/09/2011US20110136842 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers
06/09/2011US20110136841 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
06/09/2011US20110136840 Anti-infective agents
06/09/2011US20110136839 Combination of two analgesic chemicals
06/09/2011US20110136838 Chemical compounds
06/09/2011US20110136837 Mucoadhesive buccal tablets for the treatment of orofacial herpes
06/09/2011US20110136836 Methods for Altering MRNA Splicing and Treating Familial Dysautonomia and Other Mechanistically Related Disorders
06/09/2011US20110136835 Combination formulations of tranilast and allopurinol and methods related thereto
06/09/2011US20110136834 Inhibitors of e1 activating enzymes
06/09/2011US20110136833 Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof
06/09/2011US20110136832 Promoting Cycling of ApoE4 Isoform
06/09/2011US20110136830 Chromenone derivatives
06/09/2011US20110136829 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
06/09/2011US20110136828 Substituted n-oxide pyrazine derivatives
06/09/2011US20110136827 Bis-Acylated Hydroxylamine Derivatives
06/09/2011US20110136826 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
06/09/2011US20110136825 Treatment of Vasomotor Symptoms
06/09/2011US20110136824 Urotensin ii receptor antagonists
06/09/2011US20110136823 Compounds having a potentiating effect on the activity of ethionamide and uses thereof
06/09/2011US20110136822 Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof
06/09/2011US20110136821 Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase Type 1
06/09/2011US20110136820 Heterocyclic Compounds as CCR2 Antagonists
06/09/2011US20110136819 6-thioxopyridazine derivatives
06/09/2011US20110136818 Therapeutic compositions containing macitentan
06/09/2011US20110136817 Methods of identifying responders to dopamine agonist therapy
06/09/2011US20110136816 Compounds that modulate intracellular calcium
06/09/2011US20110136815 Solid oral film dosage forms and methods for making same
06/09/2011US20110136814 Diazepine and Diazocane Compounds As MC4 Agonists
06/09/2011US20110136813 Wnt protein signalling inhibitors
06/09/2011US20110136812 Solubilized topoisomerase poisons
06/09/2011US20110136811 Prokineticin 1 receptor
06/09/2011US20110136810 Antitumor agent, kit and method of treating cancer
06/09/2011US20110136809 Substituted Pyrazolyl Urea Derivatives Useful In The Treatment Of Cancer
06/09/2011US20110136808 3',6-substituted indirubins and their biological applications
06/09/2011US20110136807 Bicyclic compositions and methods for modulating a kinase cascade
06/09/2011US20110136806 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof
06/09/2011US20110136805 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same
06/09/2011US20110136804 Nicotinic Acetylcholine Receptor Ligands 101
06/09/2011US20110136803 Triazolophthalazines
06/09/2011US20110136802 Ship1 modulators and methods related thereto
06/09/2011US20110136801 Novel Compounds
06/09/2011US20110136800 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
06/09/2011US20110136799 Proline derivatives
06/09/2011US20110136798 Crystalline Forms Of A Pyridine Derivative
06/09/2011US20110136797 Cyclopropyl amines as modulators of the histamine h3 receptor
06/09/2011US20110136796 IDO Inhibitors
06/09/2011US20110136795 Tricyclic alkylaminomethyloxazolidinone derivatives
06/09/2011US20110136794 Novel pyrrole derivative having, as substituents, ureido group, aminocarbonly group and bicyclic group which may have substituent
06/09/2011US20110136793 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
06/09/2011US20110136792 Novel carboxylic acid analogs as glycogen synthase activators
06/09/2011US20110136791 Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders
06/09/2011US20110136790 Tricyclic Heterocyclic Derivatives and Methods of Use
06/09/2011US20110136789 C-met protein kinase inhibitors
06/09/2011US20110136788 Therapeutic agent for irritable bowel syndrome
06/09/2011US20110136787 Diphenyl azepane, diazepane and oxazepane derivatives and uses thereof
06/09/2011US20110136786 Method of treating mood disorders
06/09/2011US20110136785 Method of treatment
06/09/2011US20110136784 Method of Treating Anxiety Disorders
06/09/2011US20110136783 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
06/09/2011US20110136781 Imidazotriazines and imidazopyrimidines as kinase inhibitors
06/09/2011US20110136780 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak
06/09/2011US20110136779 Methods for stroke reduction in atrial fibrillation patients
06/09/2011US20110136778 Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof
06/09/2011US20110136777 Crystalline sodium salt of cephalosporin antibiotic
06/09/2011US20110136776 Copper(1)Chloride Complex of Nicotinic Acid and Pharmaceutical Compositions Containing the Same
06/09/2011US20110136775 Methods for Treating Injury Associated with Exposure to an Alkylating Species
06/09/2011US20110136774 Anti-Apoptotic Benzodiazepine Receptor Ligand Inhibitors
06/09/2011US20110136773 Pharmaceutical Uses of Lanosta-8,24-dien-3-ols
06/09/2011US20110136772 Sugar coatings and methods therefor
06/09/2011US20110136771 Orally Disintegrating Solid Dosage Forms Comprising Progestin and Methods of Making and Use Thereof
06/09/2011US20110136770 Method for Providing Emergency Contraception
06/09/2011US20110136769 Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
06/09/2011US20110136768 Imatinib mesylate for the treatment of nephrogenic systemic fibrosis
06/09/2011US20110136767 Processes for preparing piperazinium salts of kmup and use thereof
06/09/2011US20110136766 Aurora kinase inhibitors
06/09/2011US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds
06/09/2011US20110136764 Amino pyrimidine anticancer compounds
06/09/2011US20110136763 Trisubstituted boron-containing molecules
06/09/2011US20110136760 Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and other Proliferative Diseases
06/09/2011US20110136759 Moenomycin analogs, methods of synthesis, and uses thereof
06/09/2011US20110136758 Carbohydrate compositions from basidiomycete fungi as biocidal agents active against pathogens
06/09/2011US20110136757 Hypersulfated disaccharide formulations
06/09/2011US20110136756 Combination antitumor therapy
06/09/2011US20110136755 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
06/09/2011US20110136754 Novel triazole derivatives, their preparation and their application in therapeutics
06/09/2011US20110136753 Glycosylated indolecarbazoles, method for obtaining same and uses thereof
06/09/2011US20110136752 Novel antibiotics
06/09/2011US20110136751 Use of Polyphenols in the Treatment of Cancer
06/09/2011US20110136750 Compounds useful for treating neurodegenerative disorders
06/09/2011US20110136749 Compounds useful for treating neurodegenerative disorders
06/09/2011US20110136748 Novel glucopyranose derivatives, preparation thereof, and biological uses thereof
06/09/2011US20110136742 Antidepressant prodrugs
06/09/2011US20110136739 Use of S1P Receptor Agonists in Heart Diseases
06/09/2011US20110136735 Cyclohexane derivatives and uses thereof
06/09/2011US20110136734 Methods of Modulating Inflammation in Preterm Infants Using Carotenoids
06/09/2011US20110136687 METHOD FOR DETERMINING THE DEGREE OF METHYLATION OF DEFINED CYTOSINES IN GENOMIC DNA IN THE SEQUENCE CONTEXT OF 5'-CpG-3'
06/09/2011US20110136669 Continuous Fiber Layer Comprising an Active Substance on the Basis of Bio-Polymers, the use Thereof, and Method for the Production Thereof
06/09/2011US20110136221 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities